Skip to main content

Select Drug Profiles

Practice Management
A Comparison of Drug Formularies and the Potential for Cost-Savings
Andrea L. Kjos, PharmD, PhD, Jon C. Schommer, PhD, Yingli Yuan, PhD
Stakeholder Perspective
Aligning Stakeholders Can Maximize the Opportunity for Cost-Savings on Drugs
by Jeff Januska, PharmD
Read More
Practice Management
FDA’s Approval Process Borne Out by a Large Study: But Communicating Generics’ Safety and Efficacy to the Public Leaves Much to Be Desired
Dalia Buffery, MA, ABD
Read More
Original Research
Managing Dyslipidemia in Primary Care with Restricted Access to Lipid-Modifying Therapy
John T. Lynch, MPH, Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM, Jonathan Rosen, MD, Sanjay Gandhi, PhD, Michael F. Bullano, PharmD
Stakeholder Perspective
Appropriate Medication Selection Key to Cost-Effective Therapy, Patient Adherence
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Practice Management
Healthcare Reform: Quality Outcomes Measurement and Reporting
Cary Sennett, MD, PhD
Read More
FDA Approvals
Promising Oncology Drugs in the Pipeline
Caroline Helwick
Read More
Practice Management
Accountable Care Organizations in the Era of Healthcare Reform
Read More
Practice Management
The New Accountable Care Organizations and Medicare Gain-Sharing Program
Kip Piper, MA, FACHE
Read More
Practice Management
The Impact of Healthcare Reform on Payers’ Products, Provider Reimbursement, and Member Engagement
Sam Muppalla, Robert Capobianco
Read More
Practice Management
Enhanced Generic Utilization Saved US Healthcare $139.6 Billion in 2009
Dalia Buffery, MA, ABD
Read More
Practice Management
The Current State of Bundled Payments
Jim Evans
Read More
Page 225 of 244
Results 2241 - 2250 of 2438